Product Information
ARANESP 40 MCG/0.4 ML SYRINGE is a brand product labeled by Amgen Inc., priced at $752.4362 per ML under NDC 55513002104. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
40 ug/.4mL
Manufacturer
Amgen Inc.NDC
55513002104
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
5/20/2026
Active Ingredients
DARBEPOETIN ALFAApproval Type
Biologic (BLA)
FDA Application
BLA103951On Market Since
8/14/2006
Pharmacological Classes
Price Statistics
The NADAC for ARANESP 40 MCG/0.4 ML SYRINGE has been published 115 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $752.4362 per ML |
|---|---|
| All-time high | $753.6437 (Jun 12, 2024) |
| All-time low | $739.8750 (Jun 18, 2025) |
| 52-week high | $752.9162 |
| 52-week low | $739.8750 |
| Median price | $749.2744 |
| Average price | $747.8211 |
| Largest weekly change | +1.2% (Oct 22, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the darbepoetin alfa market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARANESP 40 MCG/0.4 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for ARANESP 40 MCG/0.4 ML SYRINGE, manufactured by Amgen Inc., is $752.4362 per ML (NDC 55513002104), effective Jun 24, 2026.
How has the price of ARANESP 40 MCG/0.4 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for ARANESP 40 MCG/0.4 ML SYRINGE has held within roughly two percent of its current level. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ARANESP 40 MCG/0.4 ML SYRINGE?
Since Apr 17, 2024, the NADAC for ARANESP 40 MCG/0.4 ML SYRINGE has ranged from a low of $739.8750 (Jun 18, 2025) to a high of $753.6437 (Jun 12, 2024), with a median of $749.2744 per ML.
Are there cheaper alternatives to ARANESP 40 MCG/0.4 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARANESP 40 MCG/0.4 ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures ARANESP 40 MCG/0.4 ML SYRINGE?
ARANESP 40 MCG/0.4 ML SYRINGE (NDC 55513002104) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification